Your session is about to expire
← Back to Search
Behavioural Intervention
Joint Effort App for Cannabis Use (JOINTEFFORT Trial)
N/A
Recruiting
Led By José Côté, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
JOINTEFFORT Trial Summary
This trial tests a mobile app to help safely use cannabis. Results will tell us if it's effective.
Who is the study for?
This trial is for non-medical cannabis users aged 18-35 who have used cannabis in the last month, can understand and write French, and own an iPhone. There are no specific exclusion criteria listed.Check my eligibility
What is being tested?
The study is testing 'Joint Effort', a mobile app designed to promote safe cannabis use among consumers. Participants will receive either brief normative feedback with standard information or just the app's features.See study design
What are the potential side effects?
Since this trial involves a mobile application rather than a medical intervention, traditional side effects are not applicable. However, participants may experience changes in their cannabis use habits.
JOINTEFFORT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Protective Behavioral Strategies for Marijuana (PBSM-17) used
Secondary outcome measures
Cannabis use frequency
Change in intention to take action on cannabis use
Number of days the mobile application was used
+4 moreJOINTEFFORT Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Joint Effort mobile applicationExperimental Treatment1 Intervention
The Joint Effort mobile application aims to support young adults in taking action on their cannabis use. Based on the Theory of Planned Behaviour, the content focuses on intention, attitude, and perceived behavioral control. Various intervention methods and strategies are used to address these determinants (e.g., personalized feedback, persuasive communication, self-observation, and activation of intention). The objectives include: to allow the individual to become aware (or more aware) of their cannabis use, to support the individual's decision-making process of taking action on their cannabis use, and to guide and support the establishment and sustainability of an action plan. An optional logbook-type feature (weekly journal of cannabis use) allows personalized monitoring and data collection throughout the course of the intervention.
Group II: Brief normative feedback and standard informationActive Control1 Intervention
The comparator is composed of a brief normative feedback regarding last month's frequency of cannabis use and basic reliable non-personalized information on lower-risk cannabis use (official public websites).
Find a Location
Who is running the clinical trial?
Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
128,837 Total Patients Enrolled
1 Trials studying Cannabis Use
99 Patients Enrolled for Cannabis Use
Judith Lapierre, PhDStudy ChairLaval University
Shalini Lal, PhDStudy ChairUniversité de Montréal
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I can understand, read, and write in French.I am between 18 and 35 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Joint Effort mobile application
- Group 2: Brief normative feedback and standard information
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts underway for this clinical research?
"According to details found on clinicaltrials.gov, this clinical trial is not actively seeking participants at present. It was initially posted on January 1st 2023 and has seen its last update take place on November 16th 2022; however, 130 other trials are currently in the process of recruitment."
Answered by AI
Are geriatrics being considered as participants in this scientific investigation?
"According to the requirements, only individuals aged 18-35 may join this clinical trial. By contrast, there are separate experiments catering to minors and seniors; 18 trials for those under 18 years old, and 54 studies intended for patients above 65."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger